You searched for "interventions"

2025 results found

Congenital nasolacrimal duct obstruction in trisomy 21 vs non-trisomy 21 patients

This is a retrospective case review study looking at patients who underwent intervention for congenital nasolacrimal duct obstruction (CNLDO) between January 2017 and January 2018. The authors state that patients were excluded if there was less than 60 months of...

Leber’s hereditary optic neuropathy: from lab to clinic

Leber’s hereditary optic neuropathy (LHON) was the first clinically described mitochondrial disorder (1871). This article reviews the pathophysiology and clinical features of LHON with a focus on translational research. G11778A is currently the most common mutation worldwide and is associated...

Troubleshooting in LASIK

Contemporary laser in situ keratomileusis (LASIK) is safe and effective. It remains the dominant intervention in routine refractive surgery for a good reason: predictable results, rapid visual recovery, and relatively simple strategies for revision treatment. Over 95% of patients are...

Sight Sciences marks 10,000 OMNI® procedures performed in the UK

Sight Sciences today marks a significant milestone for the OMNI® Surgical System in the United Kingdom, with more than 10,000 procedures performed across NHS and private hospitals since its UK launch in 2020. The milestone reflects the growing integration of...

Incomplete teprotumumab treatment for thyroid eye disease

This is a multi-centre retrospective analysis of clinical outcomes in patients who were on teprotumumab for thyroid eye disease but had the usual regime of eight infusions, three weeks apart, interrupted due to COVID-19. Manufacturing was suspended between Dec 2020...

Act now: Professor Serge Resnikoff on making myopia a public health priority

Over the past decade, myopia has shifted from a common childhood inconvenience to what global health leaders now call a “public health emergency in slow motion” [1]. According to Professor Serge Resnikoff, former Head of Eye Health at the World...

Life in the glaucoma laboratory

When people ask me what life in the laboratory is really like, I often pause. On one hand, it is the romantic notion of pushing back the boundaries of science with the daily rhythm of experiments, data and easily obtained...

The fragile p-value

Abdus Samad Ansari explores the limitation of the p-value and the application of the fragility index in clinical trials. Clinical trials and tribulations? The restoration of vision or more purely the gift of sight is an aspect of care that...

Moorfields Education: EyeThrive: Ophthalmic leadership and management programme

Two-day course 10 and 13 November 2023

Silicone hydrogel contact lenses versus autologous serum drops for dry eyes in Sjörgen syndrome

A total of 37 patients with Sjörgen syndrome (SS) related dry eyes reporting symptoms on standard therapy with artificial tears and anti-inflammatory drops were evaluated in this trial. They were randomly assigned to additional treatment with either balafilcon A silicone...

Myopia management

With the growing prevalence of myopia at epidemic levels in some countries and increasing number of research publications on myopia control, there is a lot of controversy regarding the management of myopia. As none of them are at present available...

Launch of the Vision and eye screening implementation handbook

The WHO Vision and Eye Care Programme has the pleasure to announce the publication of the Vision and eye screening implementation handbook (VESIH).